Literature DB >> 31730394

Genetics of COPD.

Edwin K Silverman1.   

Abstract

Although chronic obstructive pulmonary disease (COPD) risk is strongly influenced by cigarette smoking, genetic factors are also important determinants of COPD. In addition to Mendelian syndromes such as alpha-1 antitrypsin deficiency, many genomic regions that influence COPD susceptibility have been identified in genome-wide association studies. Similarly, multiple genomic regions associated with COPD-related phenotypes, such as quantitative emphysema measures, have been found. Identifying the functional variants and key genes within these association regions remains a major challenge. However, newly identified COPD susceptibility genes are already providing novel insights into COPD pathogenesis. Network-based approaches that leverage these genetic discoveries have the potential to assist in decoding the complex genetic architecture of COPD.

Entities:  

Keywords:  COPD; genetic association; network medicine; sequencing; subtyping

Year:  2019        PMID: 31730394     DOI: 10.1146/annurev-physiol-021317-121224

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  21 in total

Review 1.  Impaired Alveolar Re-Epithelialization in Pulmonary Emphysema.

Authors:  Chih-Ru Lin; Karim Bahmed; Beata Kosmider
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

2.  Identification of the key genes in chronic obstructive pulmonary disease by weighted gene co-expression network analysis.

Authors:  Zhefan Xie; Tingting Xia; Dongxue Wu; Li Che; Wei Zhang; Xingdong Cai; Shengming Liu
Journal:  Ann Transl Med       Date:  2022-06

Review 3.  Genetic Variants Associated with Chronic Obstructive Pulmonary Disease Risk: Cumulative Epidemiological Evidence from Meta-Analyses and Genome-Wide Association Studies.

Authors:  Caiyang Liu; Ran Ran; Xiaoliang Li; Gaohua Liu; Xiaoyang Xie; Ji Li
Journal:  Can Respir J       Date:  2022-06-09       Impact factor: 2.130

Review 4.  Pulmonary Functional Imaging: Part 2-State-of-the-Art Clinical Applications and Opportunities for Improved Patient Care.

Authors:  Warren B Gefter; Kyung Soo Lee; Mark L Schiebler; Grace Parraga; Joon Beom Seo; Yoshiharu Ohno; Hiroto Hatabu
Journal:  Radiology       Date:  2021-04-13       Impact factor: 29.146

5.  Analysis of the association of ANO3/MUC15, COL4A4, RRBP1, and KLK1 polymorphisms with COPD susceptibility in the Kashi population.

Authors:  Lifeng Tang; Xuemei Zhong; Hui Gong; Maimaitiaili Tuerxun; Tao Ma; Jie Ren; Chengxin Xie; Aifang Zheng; Zulipikaer Abudureheman; Ayiguzali Abudukadeer; Paierda Aini; Subinuer Yilamujiang; Li Li
Journal:  BMC Pulm Med       Date:  2022-05-05       Impact factor: 3.320

6.  Artificial Intelligence-Aided Precision Medicine for COVID-19: Strategic Areas of Research and Development.

Authors:  Enrico Santus; Nicola Marino; Davide Cirillo; Emmanuele Chersoni; Arnau Montagud; Antonella Santuccione Chadha; Alfonso Valencia; Kevin Hughes; Charlotta Lindvall
Journal:  J Med Internet Res       Date:  2021-03-12       Impact factor: 5.428

7.  Bronchial Epithelial Cell Transcriptomics: A Tool to Monitor and Predict Chronic Obstructive Pulmonary Disease Progression?

Authors:  Chiara De Santi; Catherine M Greene
Journal:  Am J Respir Cell Mol Biol       Date:  2021-04       Impact factor: 6.914

8.  Endothelial HIF-2α as a Key Endogenous Mediator Preventing Emphysema.

Authors:  Shravani Pasupneti; Wen Tian; Allen B Tu; Petra Dahms; Eric Granucci; Aneta Gandjeva; Menglan Xiang; Eugene C Butcher; Gregg L Semenza; Rubin M Tuder; Xinguo Jiang; Mark R Nicolls
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 30.528

Review 9.  Dysregulated Cell Signaling in Pulmonary Emphysema.

Authors:  Chih-Ru Lin; Karim Bahmed; Beata Kosmider
Journal:  Front Med (Lausanne)       Date:  2022-01-03

Review 10.  Early Diagnosis and Real-Time Monitoring of Regional Lung Function Changes to Prevent Chronic Obstructive Pulmonary Disease Progression to Severe Emphysema.

Authors:  Tony Jung; Neeraj Vij
Journal:  J Clin Med       Date:  2021-12-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.